
Bioserve Scientific Solutions Private Limited
About Bioserve Scientific Solutions Private Limited
Data last updated:
Bioserve Scientific Solutions Private Limited is a private limited company based in Delhi, India, recognised as a startup by DPIIT. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 04 February 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2022PTC393375.
The company has an authorised share capital of ₹6 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors Manish Kumar and Piyush Nath.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No. 402 Plot No. 3, Block – G Tsl – 3 Corner Lsc Kondli Gharoli Mayur Vihar Phase – 3, Delhi, India – 110096.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.1 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹3.68 Lakh (net margin 3.3%) and EBITDA of ₹3.99 Lakh (EBITDA margin 3.6%).
Bioserve Scientific Solutions Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0031697).
Company details
Recognitions & Rankings of Bioserve Scientific Solutions
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-02-0031697
Contact details
Bioserve Scientific Solutions Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressUnit No. 402 Plot No. 3, Block – G Tsl – 3 Corner Lsc Kondli Gharoli Mayur Vihar Phase – 3, Delhi, India – 110096
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Bioserve Scientific Solutions Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bioserve Scientific Solutions is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bioserve Scientific Solutions Private Limited, buy the company report.
Financials of Bioserve Scientific Solutions Private Limited
FY 2025 filings availableBioserve Scientific Solutions Private Limited reported revenue of ₹1.1 Cr (up 259% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 259% in the latest year. EBITDA rose 170% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹3.99 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹3.68 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 3.6% | ||
| Net Profit Margin | 3.3% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Bioserve Scientific Solutions Private Limited, buy the company report.
Board of directors of Bioserve Scientific Solutions Private Limited
Bioserve Scientific Solutions has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Kumar Also directs: Bromed Systems Private Limited | Director | 25 Dec 2023 | 2 Years 10 Months | Current |
| Piyush Nath | Director | 05 Jan 2026 | 0 Years 9 Months | Current |
Peer comparison
Bioserve Scientific Solutions Private Limited is compared with the 8 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| GV Surgicals Private Limited | ₹1.12 Cr (FY 2025) | 43.0% | Pune, Maharashtra, India | |||
| Pranju Agrimart Private Limited | ₹1.12 Cr (FY 2024) | -45.0% | Ghaziabad, Uttar Pradesh, India | |||
| Tricent Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2024) | 7056835.0% | Lucknow, Uttar Pradesh, India | |||
| Dynamic Infra and Services (India) Private Limited (OPC) | ₹1.11 Cr (FY 2023) | -2.0% | Patna, Bihar, India | |||
| Bioserve Scientific Solutions Private Limitedthis company | ₹1.1 Cr (FY 2024) | ₹3.68 Lakh | 3.3% | 259.0% | Delhi, India | |
| Biolab Equipt Private Limited | ₹1.1 Cr (FY 2022) | -68.0% | Kolkata, West Bengal, India | |||
| Machdeal India Private Limited | ₹1.1 Cr (FY 2025) | 344.0% | Saoner, Maharashtra, India | |||
| Iris Healthcare Technologies Private Limited | ₹1.1 Cr (FY 2025) | -89.0% | Mumbai, Maharashtra, India | |||
| Blucrab Pharma Private Limited | ₹1.1 Cr (FY 2025) | -28.0% | Vastral, Gujarat, India |
To see the full peer comparison of Bioserve Scientific Solutions Private Limited, buy the company report.
Auditor
Bioserve Scientific Solutions Private Limited is audited by RAVINDER KUMAR & COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAVINDER KUMAR & COMPANY | FY 2023 | 021989C |
Shareholding
The shareholding of Bioserve Scientific Solutions Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Bioserve Scientific Solutions Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bioserve Scientific Solutions Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bioserve Scientific Solutions Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Bioserve Scientific Solutions Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Bioserve Scientific Solutions Private Limited has 6 board changes on record since 2022: 2 appointments and 4 cessations. The latest: Gaurav Srivastava ceased to be Director on 07 Jan 2026.
Frequently asked questions
Bioserve Scientific Solutions is an active private limited company based in Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 04 February 2022 (4+ years old) and is registered under CIN U24290DL2022PTC393375.
Bioserve Scientific Solutions has 2 current directors:
- Manish Kumar - Director
- Piyush Nath - Director
The latest financial statements of Bioserve Scientific Solutions on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Bioserve Scientific Solutions is U24290DL2022PTC393375. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bioserve Scientific Solutions was incorporated on 04 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Bioserve Scientific Solutions by revenue are GV Surgicals Private Limited, Pranju Agrimart Private Limited, Tricent Pharmaceuticals Private Limited, Dynamic Infra and Services (India) Private Limited (OPC), Biolab Equipt Private Limited and 3 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).
Gaurav Srivastava ceased to be Director on 07 Jan 2026. Piyush Nath was appointed as Director on 05 Jan 2026. Ekta Chechi ceased to be Director on 30 Dec 2023. Bioserve Scientific Solutions has 6 board changes on record in total.
Yes, Bioserve Scientific Solutions is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Bioserve Scientific Solutions is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0031697).
The registered office of Bioserve Scientific Solutions is at Unit No. 402 Plot No. 3, Block – G Tsl – 3 Corner Lsc Kondli Gharoli Mayur Vihar Phase – 3, Delhi, India – 110096.
Bioserve Scientific Solutions operates in the healthcare industry, in the medical equipment retail and distribution segment.